D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain

EMBO Journal

Volumn 17, Issue 1, 1998, Pages 255-268

  Ganter, Brigitte ^a   Fu, Shu Ling ^a,b   Lipsick, Joseph S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

D type cyclins; Myb DNA binding domain; Repeat R1; Transcription; v Myb

Indexed keywords

CYCLIN D1;

ANIMAL CELL; ARTICLE; BLAST CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE REPRESSION; NONHUMAN; ONCOGENE; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN STABILITY; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE, TRANSFORMED; CHICKENS; CYCLIN D1; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA-BINDING PROTEINS; ONCOGENE PROTEINS V-MYB; PROTEIN BINDING; RETROVIRIDAE PROTEINS, ONCOGENIC; TRANS-ACTIVATION (GENETICS);

EID: 0032472332     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.1.255     Document Type: Article

References (72)

1. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. (1989) Current Protocols in Molecular Biology. John Wiley & Sons, New York, pp. 9.7.12-9.7.14.
2. Aziz, N., Miglarese, M.R., Hendrickson, R.C., Shabanowitz, J., Sturgill, T.W., Hunt, D.F. and Bender, T.P. (1995) Modulation of c-myb-induced transcription activation by a phosphorylation site near the negative regulatory domain. Proc. Natl Acad. Sci. USA, 92, 6429-6433.
3. Baluda, M.A. and Reddy, E.P. (1994) Anatomy of an integrated avian myeloblastosis provirus: structure and function. Oncogene, 9, 2761-2774.
4. Bartel, P.L., Chien, C.-T., Sternglanz, R. and Fields, S. (1993) Using the two-hybrid system to detect protein-protein interactions. In Hartley, D.A. (ed.), Cellular Interactions in Development: A Practical Approach, Oxford University Press, Oxford, pp. 153-179.
5. Beijersbergen, R.L., Carlee, L., Kerkhoven, R.M. and Bernards, R. (1995) Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev., 9, 1340-1353.
6. Boyle, W.J., Lampert, M.A., Lipsick, J.S. and Baluda, M.A. (1984) Avian myeloblastosis virus and E26 virus oncogene products are nuclear proteins. Proc. Natl Acad. Sci. USA, 81, 4265-4269.
7. Boyle, W.J., Van Der Geer, P. and Hunter, T. (1991) Phosphopeptide mapping and phosphoamine acid analysis by two-dimensional separation on thin-layer cellulose plates. In Hunter, T. and Sefton, B.M. (eds), Methods In Enzymology, Vol. 201. Protein Phosphorylation, Part B. Analysis Of Protein Phosphorylation, Protein Kinase Inhibitors, and Protein Phosphatases. Academic Press, San Diego, pp. 110-149.
8. Candau, R., Moore, P.A., Wang, L., Barlev, N., Ying, C.Y., Rosen, C.A. and Berger, S.L. (1996) Identification of human proteins functionally conserved with the yeast putative adaptors ADA2 and GCN5. Mol. Cell. Biol., 16, 593-602.
9. Catron, K.M., Purkerson, P.C., Isakson, P.C. and Bender, T.P. (1992) Constitutive versus cell cycle regulation of c-myb mRNA expression correlates with development stages in murine B lymphoid tumors. J. Immunol., 148, 934-942.
10. Chen, C.H. and Okayama, H. (1987) High-efficient transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7, 2745-2752.
11. Chen, J.H. (1980) Expression of endogenous avian myeloblastosis virus information in different chicken cells. J. Virol., 36, 162-170.
12. Chen, R.-H. and Lipsick, J.S. (1993) Differential transcriptional activation by v-Myb and c-Myb in animal cells and Saccharomyces cerevisiae. Mol. Cell. Biol., 13, 4423-4431.
13. Chen, R.-H., Fields, S. and Lipsick, J.S. (1995) Dissociation of transcriptional activation and oncogenic transformation by v-Myb. Oncogene, 11, 1771-1779.
14. Cooper, J.P., Nimmo, E.R., Allshire, R.C. and Cech, T.R. (1997) Regulation of telomere length and function by a myb-domain protein in fission yeast. Nature, 385, 744-747.
15. de Wet, J., Wood, K.V., DeLucas, M., Helsinki, D.R. and Subramani, S. (1987) Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol., 7, 725-737.
16. Dini, P.W. and Lipsick, J.S. (1993) Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo. Mol. Cell. Biol., 13, 7334-7348.
17. Duprey, S.P. and Boettiger, D. (1985) Developmental regulation of c-myb in normal myeloid progenitor cells. Proc. Natl Acad. Sci. USA, 82, 6937-6941.
18. Engelke, U., Smarda, J. and Lipsick, J.S. (1995a) By-pass of TPA-induced differentiation and cell cycle arrest by the c-Myb DNA-binding domain. Oncogene, 11, 735-741.
19. Engelke, U., Whittaker, L. and Lipsick, J.S. (1995b) Weak transcriptional activation is sufficient for transformation by v-Myb. J. Virol., 208, 467-477.
20. Evan, G.I., Lewis, G.K. and Bishop, J.M. (1984) Isolation of monoclonal antibodies specific for the products of the avian oncogene myb. Mol. Cell. Biol., 4, 2843-2850.
21. Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kato, J. and Livingston, D.M. (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73, 487-497.
22. Feilotter, H.E., Hannon, G.J., Ruddell, C.J. and Beach, D. (1994) Construction of an improved host strain for two-hybrid screening. Nucleic Acids Res., 22, 1502-1503.
23. Ferrao, P., Macmillan, E.M., Ashman, L.K. and Gonda, T.J. (1995) Enforced expression of full length c-Myb leads to density-dependent transformation of murine haematopoietic cells. Oncogene, 11, 1631-1638.
24. Fu, S.-L. and Lipsick, J.S. (1996) FAETL motif required for leukemic transformation by v-Myb. J. Virol. 70, 5600-5610.
25. Fu, S.-L. and Lipsick, J.S. (1997) Constitutive expression of full-length c-Myb transforms avian cells characteristic of both the monocytic and granulocytic lineages. Cell Growth Diff., 8, 35-45.
26. Fuerstenberg, S., Leitner, I., Schroeder, C., Schwarz, H., Vennstrom, B. and Beug, H. (1992) Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype. EMBO J., 11, 3355-3365.
27. Ganter, B. and Lipsick, J.S. (1997) Myb binding sites within the N-ras promoter repress transcription. Oncogene, 15, 193-202.
28. Garcia, A., Lamontagne, K., Reavis, D., Stober-Graesser, U. and Lipsick, J.S. (1991) Determinants of sequence-specific DNA-binding by p48v-myb. Oncogene, 6, 265-274.
29. Gietz, R.D. and Sugino, A. (1988) New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene, 74, 527-534.
30. Gonda, T.J. and Metcalf, D. (1984) Expression of myb, myc and fos protooncogenes during the differentiation of a murine myeloid leukemia. Nature, 310, 249-251.
31. Gonda, T.J., Sheiness, D.K. and Bishop, J.M. (1982) Transcripts from the cellular homologs of retroviral oncogenes: distribution among chicken tissues. Mol. Cell, Biol., 2, 617-624.
32. Graesser, F.A., Graf, T. and Lipsick, J.S. (1991) Protein truncation is required for the activation of the c-myb proto-oncogene. Mol. Cell. Biol., 11, 3987-3996.
33. Guthrie, C. and Fink, G.R. (1991) Guide to Yeast Genetics and Molecular Biology. Academic Press, San Diego.
34. Hinds, P.W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S.I. and Weinberg, R.A. (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 70, 993-1006.
35. Hinds, P.W., Dowdy, S.F., Eaton, E.N., Arnold, A. and Weinberg, R.A. (1994) Function of a human cyclin gene as an oncogene. Proc. Natl Acad. Sci. USA, 91, 709-713.
36. Hirai, H. and Sherr, C.J. (1996) Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1. Mol. Cell. Biol., 16, 6457-6467.
37. Hörlein, A.J. et al. (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature, 377, 397-404.
38. Ibanez, C.E. and Lipsick, J.S. (1990) trans Activation of gene expression by v-myb. Mol. Cell. Biol., 10, 2285-2293.
39. Introna, M., Golay, J., Frampton, J., Nakano, T., Ness, S.A. and Graf, T. (1994) The myb oncogene family of transcription factors: potent regulators of hematopoietic cell proliferation and differentiation. Semin. Cancer Biol., 5, 113-124.
40. Ito, H., Fukuda, Y., Murata, K. and Kimura, A. (1983) Transformation of intact yeast cells treated with alkali cations. J. Bacteriol., 153, 163-168.
41. Kassavetis, G.A., Nguyen, S.T., Kobayashi, R., Kumar, A., Geiduschek, E.P. and Pisano, M. (1995) Cloning, expression, and function of TFC5, the gene encoding the B' component of the Saccharomyces cerevisiae RNA polymerase III transcription factor TFIIIB. Proc. Natl Acad. Sci. USA, 92, 9786-9790.
42. Klempnauer, K.-H., Ramsay, G., Bishop, J.M., Moscovici, M.G., Moscovici, C., McGrath, J.P. and Levinson, A.D. (1983) The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb. Cell, 36, 345-355.
43. Klempnauer, K.-H., Symonds, B., Evan, G.I. and Bishop, J.M. (1984) Subcellular localization of proteins encoded by oncogenes of avian myeloblastosis virus and avian leukemia virus E26 and by the chicken c-myb gene. Cell, 37, 537-547.
44. König, P., Giraldo, R., Chapman, L. and Rhodes, D. (1996) The crystal structure of the DNA-binding domain of yeast rap1 in complex with telomeric DNA. Cell, 85, 125-136.
45. Kurokawa, R., Soderstrom, M., Horlein, A., Halachmi, S., Brown, M., Rosenfeld, M.G. and Glass, C.K. (1995) Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature, 377, 451-454.
46. Lipsick, J.S. (1996) One billion years of myb. Oncogene, 13, 223-235.
47. Lipsick, J.S. and Boyle, W.J. (1987) c-myb protein expression is a late event during T-lymphocyte activation. Mol. Cell. Biol., 7, 3358-3360.
48. Luscher, B., Christenson, E., Litchfield, D.W., Krebs, E.G. and Eisenman, R.N. (1990) Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature, 344, 517-521.
49. McClinton, D., Stafford, J, Brents, L., Bender, T.P. and Kuehl, W.M. (1990) Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene. Mol. Cell. Biol., 10, 705-710.
50. Moscovici, C., Zeller, N. and Moscovici, M.G. (1982) Expression of differentiated function in cancer cells. In Revoltella, R.F., Basilico, C., Potori, G.M., Rovera, G. and Subak-Sharpe, J.H. (eds), Continuous Lines of AMV-transformed Nonproducer Cells: Growth and Oncogenic Potential in the Chicken Embryo. Raven Press, New York, pp. 325-449.
51. Ness, S.A., Marknell, A. and Graf, T. (1989) The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell, 59, 1115-1125.
52. Ogata, K., Morikawa, S., Nakamura, H., Sekikawa, A., Inoue, T., Kanai, H., Sarai, A., Ishii, S. and Nishimura, Y. (1994) Solution structure of a specific DNA complex of the myb DNA-binding domain with cooperative recognition helices. Cell, 79, 639-648.
53. Pessano, S., Gazzolo, L. and Moscovici, C. (1979) The effect of a tumor promoter on avian leukemic cells. Microbiologica, 2, 379-392.
54. Reed, J.C., Alpers, J.D., Nowell, P.C. and Hoover, R.G. (1986) Sequential expression of proto-oncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. Proc. Natl Acad. Sci. USA, 83, 3982-3986.
55. Resnitzky, D. and Reed, S.I. (1995). Different roles for cyclins D1 and E in regulation of the G-1-to-S transition. Mol. Cell. Biol., 15, 3463-3469.
56. Sala, A. et al. (1997) Activation of human B-Myb by cyclins. Proc. Natl Acad. Sci. USA, 94, 532-536.
57. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
58. Schiestl, R.H. and Gietz, R.D. (1989) High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet., 16, 339-346.
59. Serrano, M., Hannon, G.J. and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D-cdk4. Nature, 366, 704-707.
60. Sleeman, J.P. (1993) Xenopus A-myb is expressed during early spermatogenesis. Oncogene, 8, 1931-1941.
61. Smarda, J. and Lipsick, J.S. (1994) C-myb prevents TPA-induced differentiation and cell death in v-Myb transformed monoblasts. Oncogene, 9, 237-245.
62. Tanikawa, J., Yasukawa, T., Enari, M., Ogata, K., Nishimura, Y., Ishii, S. and Sarai, A. (1993) Recognition of specific DNA sequences by the c-myb proto-oncogene product: role of three repeat units in the DNA-binding domain. Proc. Natl Acad. Sci. USA, 90, 9320-9324.
63. Thompson, C.B., Challoner, P.B., Neiman, P.E. and Groudine, M. (1986) Expression of the c-myb proto-oncogene during cellular proliferation. Nature, 319, 374-380.
64. Torelli, G.M., Selleri, L., Donelli, A., Ferrari, S., Emilia, G., Veturelli, D., Moretti, L. and Torelli, U.L. (1985) Activation of c-myb expression of phytohemagglutinin stimulation in normal human T lymphocytes. Mol. Cell. Biol., 5, 2874-2877.
65. Travali, S., Ferber, A., Reiss, K., Sell, C., Koniecki, J., Calabretta, B. and Baserga, R. (1991) Effect of the myb gene product on expression of the PCNA gene in fibroblasts. Oncogene, 6, 887-894.
66. Treisman, R. (1986) Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum response. Cell, 46, 567-574.
67. Van Steensel, B. and De Lange, T. (1997) Control of telomere length by the human telomeric protein TRF1. Nature, 385, 740-743.
68. Wang, W., Xue, Y, Zhou, S., Kuo, A., Cairns, B.R. and Crabtree, G.R. (1996) Diversity and specialization of mammalian SWI-SNF complexes. Genes Dev., 10, 2117-2130.
69. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
70. Westin, E.H., Gallo, R.C. Arya, S.K., Eva, A., Souza, L.M., Baluda, M.A., Aaronson, S.A. and Wong-Staal, F. (1982) Differential expression of the AMV gene in human hematopoietic cells. Proc. Natl Acad. Sci. USA, 79, 2194-2198.
71. Ziebold, U., Bartsch, O., Marais, R., Ferrari, S. and Klempnauer, K.-H. (1997) Phosphorylation and activation of B-myb by cyclin A-cdk2. Curr. Biol., 7, 253-260.
72. Zwijsen, R.M.L., Wientjens, E., Klompmaker, R., Van Der Sman, J., Bernards, R. and Michalides, R.J.A.M. (1997) CDK-independent activation of estrogen receptor by cyclin D1. Cell, 88, 405-415.